Biorelate Company

Biorelate provides biomedical research services. It engages in the research of biomarkers for the diagnosis of prostate cancer; target validation; and new drug development services. Daniel Jamison founded Biorelate in 2014. It has its headquarters in Oldham in the United Kingdom.
Technology: Big Data, Biotechnology, Health Care, Life Science, Medical
Industry: Early Drug Development
Headquarters: Oldham, Oldham, United Kingdom
Founded Date: 2014-01-01
Employees Number: 11-50
Funding Status: Grant
Investors Number: 4
Total Funding: 1063423
Estimated Revenue: $1M to $10M
Last Funding Date: 2018-09-18
Last Funding Type: Venture - Series Unknown

Visit Website
Register and Claim Ownership